Skip to main content
Premium Trial:

Request an Annual Quote

Rubicon, Agendia Ink Clinical Supply Pact

NEW YORK (GenomeWeb News) – Rubicon Genomics said today that molecular diagnostics company Agendia will use Rubicon's whole-genome RNA amplification technology with Agendia's breast cancer diagnostic tests.

Under a clinical supply agreement, Agendia will incorporate Rubicon's TransPlex technology into the analysis of formalin fixed, paraffin-embedded patient samples for use in testing with its Symphony suite of breast cancer diagnostics.

Ann Arbor, Mich.-based Rubicon said its TransPlex kits are aimed at improving the quality and quantity of nucleic acids extracted from FFPE samples to enable accurate and consistent analysis of molecular diagnostic tests.

In a statement, Rubicon CEO James Koziarz called the deal an important milestone for his firm. "This supply agreement with cancer diagnostics pioneer Agendia represents our first large-scale commercial partnership with a provider of clinical diagnostic tests, and we expect it to be the first of many going forward," he said.

Financial and other terms of the deal were not disclosed.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.